Inhibition of neo-intimal hyperplasia in porcine coronary arteries utilizing a novel paclitaxel-coated scoring balloon catheter

Catheterization and Cardiovascular Interventions

Volumn 84, Issue 7, 2014, Pages 1089-1098

  Cremers, Bodo ^a   Schmitmeier, Stephanie ^b   Clever, Yvonne P ^a   Gershony, Gary ^c   Speck, Ulrich ^d   Scheller, Bruno ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b INNORA GMBH   (Germany)

^c John Muir Hospital   (United States)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Drug coated balloon; Restenosis; Revascularization; Scoring balloon

Indexed keywords

PACLITAXEL; ANTINEOPLASTIC AGENT; BIOMATERIAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON CATHETER; CONTROLLED STUDY; CORONARY ARTERY; CORONARY STENT; DOSE RESPONSE; DRUG ABSORPTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG RELEASE; DRUG SAFETY; DRUG TOLERABILITY; HEART LEFT VENTRICLE EJECTION FRACTION; IN VITRO STUDY; IN VIVO STUDY; MALE; MATERIAL COATING; NONHUMAN; PTCA CATHETER; SCORING BALLOON CATHETER; SWINE; VASCULITIS; ANIMAL; CORONARY BLOOD VESSEL; CORONARY STENOSIS; DEVICES; DISEASE MODEL; DRUG EFFECTS; EQUIPMENT DESIGN; HEART CATHETER; HYPERPLASIA; INTIMA; PATHOLOGY; PIG; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, BALLOON, CORONARY; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARDIAC CATHETERS; COATED MATERIALS, BIOCOMPATIBLE; CORONARY STENOSIS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; EQUIPMENT DESIGN; HYPERPLASIA; MALE; PACLITAXEL; SWINE; TUNICA INTIMA;

EID: 84911888229     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25296     Document Type: Article

References (37)

1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R. A randomized comparison of a sirolimuseluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780.
2. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drugeluting stents in humans: Delayed healing and late thrombotic risk. J Am College Cardiol 2006;48:193-202.
3. Scheller B, Speck U, Abramjuk C, Bernhardt U, Bohm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 2004;110:810- 814.
4. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Bohm M, Speck U. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006; 355:2113-2124.
5. Speck U, Cremers B, Kelsch B, Biedermann M, Clever YP, Schaffner S, Mahnkopf D, Hanisch U, Bohm M, Scheller B. Do pharmacokinetics explain persistent restenosis inhibition by a single dose of paclitaxel? Circ Cardiovasc Interv. 2012;5:392-400.
6. Cremers B, Milewski K, Clever YP, Aboodi MS, Biedermann M, Thim T, Kelsch B, Kaluza GL, Scheller B, Granada JF. Long-term effects on vascular healing of bare metal stents delivered via paclitaxel-coated balloons in the porcine model of restenosis. Catheter Cardiovasc Interv 2012;80:603-610.
7. Speck U, Scheller B, Abramjuk C, Grossmann S, Mahnkopf D, Simon O. Inhibition of restenosis in stented porcine coronary arteries: Uptake of paclitaxel from angiographic contrast media. Investig Radiol 2004;39:182-186.
8. Speck U, Scheller B, Abramjuk C, Breitwieser C, Dobberstein J, Boehm M, Hamm B. Neointima inhibition: Comparison of effectiveness of non-stent-based local drug delivery and a drugeluting stent in porcine coronary arteries. Radiology 2006;240: 411-418.
9. Cremers B, Biedermann M, Mahnkopf D, Bohm M, Scheller B. Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model. Clin Res Cardiol 2009;98:325-330.
10. Cremers B, Speck U, Kaufels N, Mahnkopf D, Kuhler M, Bohm M, Scheller B. Drug-eluting balloon: Very short-term exposure and overlapping. Thromb Haemost 2009;101:201-206.
11. Posa A, Nyolczas N, Hemetsberger R, Pavo N, Petnehazy O, Petrasi Z, Sangiorgi G, Gyongyosi M. Optimization of drugeluting balloon use for safety and efficacy: Evaluation of the 2nd generation paclitaxel-eluting dior-balloon in porcine coronary arteries. Catheter Cardiovasc Interv 2010;76:395-403.
12. Kelsch B, Scheller B, Biedermann M, Clever YP, Schaffner S, Mahnkopf D, Speck U, Cremers B. Dose response to paclitaxelcoated balloon catheters in the porcine coronary overstretch and stent implantation model. Investig Radiol 2011;46:255-263.
13. Cremers B, Kelsch B, Clever YP, Hattangadi N, Mahnkopf D, Speck U, Taupitz M, Scheller B. Inhibition of neointimal proliferation after bare metal stent implantation with low-pressure drug delivery using a paclitaxel-coated balloon in porcine coronary arteries. Clin Res Cardiol 2012;101:385-391.
14. Cremers B, Toner JL, Schwartz LB, von Oepen R, Speck U, Kaufels N, Clever YP, Mahnkopf D, Beohm M, Scheller B. Inhibition of neointimal hyperplasia with a novel zotarolimus coated balloon catheter. Clin Res Cardiol. 2012;101:469-476.
15. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwalder U, Beregi JP, Claussen CD, Oldenburg A, Scheller B, Speck U. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008;358:689-699.
16. Werk M, Langner S, Reinkensmeier B, Boettcher HF, Tepe G, Dietz U, Hosten N, Hamm B, Speck U, Ricke J. Inhibition of restenosis in femoropopliteal arteries: Paclitaxel-coated versus uncoated balloon: Femoral paclitaxel randomized pilot trial. Circulation 2008;118:1358-1365.
17. Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 2009;119:2986-2994.
18. Unverdorben M, Kleber FX, Heuer H, Figulla HR, Vallbracht C, Leschke M, Cremers B, Hardt S, Buerke M, Ackermann H, Boxberger M, Degenhardt R, Scheller B. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol 2010;99:165-174.
19. Mathey DG, Wendig I, Boxberger M, Bonaventura K, Kleber FX. Treatment of bifurcation lesions with a drug-eluting balloon: The pepcad v (paclitaxel eluting ptca balloon in coronary artery disease) trial. EuroIntervention 2011;7 (Suppl K):K61- K65.
20. Wohrle J, Birkemeyer R, Markovic S, Nguyen TV, Sinha A, Miljak T, Spiess J, Rottbauer W, Rittger H. Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease. Heart 2011;97:1338-1342.
21. Habara S, Mitsudo K, Kadota K, Goto T, Fujii S, Yamamoto H, Katoh H, Oka N, Fuku Y, Hosogi S, Hirono A, Maruo T, Tanaka H, Shigemoto Y, Hasegawa D, Tasaka H, Kusunose M, Otsuru S, Okamoto Y, Saito N, Tsujimoto Y, Eguchi H, Miyake K, Yoshino M. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. JACC Cardiovasc Interv 2011;4:149-154.
22. Vajda Z, Guthe T, Perez MA, Heuschmid A, Schmid E, Bazner H, Henkes H. Neurovascular in-stent stenoses: Treatment with conventional and drug-eluting balloons. AJNR Am J Neuroradiol 2011;32:1942-1947.
23. Schmidt A, Piorkowski M, Werner M, Ulrich M, Bausback Y, Braunlich S, Ick H, Schuster J, Botsios S, Kruse HJ, Varcoe RL, Scheinert D. First experience with drug-eluting balloons in infrapopliteal arteries restenosis rate and clinical outcome. J Am Coll Cardiol 2011;58:1105-1109.
24. Scheller B, Clever YP, Kelsch B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Speck U, Bohm M, Cremers B. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. JACC Cardiovasc Interv 2012;5:323-330.
25. Cremers B, Clever Y, Schaffner S, Speck U, Bohm M, Scheller B. Treatment of coronary in-stent restenosis with a novel paclitaxel urea coated balloon. Miner Cardioangiol 2010;58:583-588.
26. Rittger H, Brachmann J, Sinha AM, Waliszewski M, Ohlow M, Brugger A, Thiele H, Birkemeyer R, Kurowski V, Breithardt OA, Schmidt M, Zimmermann S, Lonke S, von Cranach M, Nguyen TV, Daniel WG, Wohrle J. A randomized, multicenter, singleblinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: The pepcad-des study. J Am Coll Cardiol 2012;59:1377-1382.
27. Latib A, Colombo A, Castriota F, Micari A, Cremonesi A, De Felice, F, Marchese A, Tespili M, Presbitero P, Sgueglia GA, Buffoli F, Tamburino C, Varbella F, Menozzi A. A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: The bello (balloon elution and late loss optimization) study. J Am Coll Cardiol 2012;60:2473-2480.
28. Byrne RA, Neumann FJ, Mehilli J, Pinieck S, Wolff B, Tiroch K, Schulz S, Fusaro M, Ott I, Ibrahim T, Hausleiter J, Valina C, Pache J, Laugwitz KL, Massberg S, Kastrati A, for the I-Di. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (isar-desire 3): A randomised, open-label trial. Lancet 2013;381:461-467.
29. Fonseca A, Costa J de R Jr, Abizaid A, Feres F, Abizaid AS, Costa R, Staico R, Mattos LA, Sousa AG, Grube E, Sousa JE. Intravascular ultrasound assessment of the novel angiosculpt scoring balloon catheter for the treatment of complex coronary lesions. J Invasive Cardiol 2008;20:21-27.
30. de Ribamar Costa, J Jr, Mintz GS, Carlier SG, Mehran R, Teirstein P, Sano K, Liu X, Lui J, Na Y, Castellanos C, Biro S, Dani L, Rinker J, Moussa I, Dangas G, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB. Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon. Am J Cardiol 2007;100:812- 817.
31. Scheinert D, Peeters P, Bosiers M, O'Sullivan G, Sultan S, Gershony G. Results of the multicenter first-in-man study of a novel scoring balloon catheter for the treatment of infrapopliteal peripheral arterial disease. Catheter Cardiovasc Interv 2007;70:1034-1039.
32. Bosiers M, Deloose K, Cagiannos C, Verbist J, Peeters P. Use of the angiosculpt scoring balloon for infrapopliteal lesions in patients with critical limb ischemia: 1-year outcome. Vascular 2009;17:29-35.
33. Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR. Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model. J Am Coll Cardiol 1992;19:267-274.
34. Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998;31:224-230.
35. Indermuehle A, Bahl R, Lansky AJ, Froehlich GM, Knapp G, Timmis A, Meier P. Drug-eluting balloon angioplasty for instent restenosis: A systematic review and meta-analysis of randomised controlled trials. Heart 2013;99:327-333.
36. Schwartz RS, Edelman E, Virmani R, Carter A, Granada JF, Kaluza GL, Chronos NA, Robinson KA, Waksman R, Weinberger J, Wilson GJ, Wilensky RL. Drug-eluting stents in preclinical studies: Updated consensus recommendations for preclinical evaluation. Circ Cardiovasc Interv 2008;1:143-153.
37. Kong J, Hou J, Ma L, Xing L, Jia H, Liu H, Zhang S, Yu B, Jang IK. Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis. Arch Cardiovasc Dis 2013;106:79-85.